-
1
-
-
0036332286
-
Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China [J]
-
Xiao Z, Hao Y, Liu B, et al. Indirubin and meisoindigo in the treatment of chronic myelogenous leukemia in China [J]. Leuk Lymphoma, 2002,43:1763-1768.
-
(2002)
Leuk Lymphoma
, vol.43
, pp. 1763-1768
-
-
Xiao, Z.1
Hao, Y.2
Liu, B.3
-
2
-
-
0033994955
-
Clinical strategy for the development of angiogenesis inhibition [J]
-
Carter SK. Clinical strategy for the development of angiogenesis inhibition [J]. Oncologist, 2000, 5 (Suppl1):51-54.
-
(2000)
Oncologist
, vol.5
, Issue.SUPPL.1
, pp. 51-54
-
-
Carter, S.K.1
-
3
-
-
0033883776
-
SU6668 is a potent antlagiogenic and antitumor agent that induces regression of established tumors [J]
-
Laird AD, Vajkoczy P, Shawver LK, et al. SU6668 is a potent antlagiogenic and antitumor agent that induces regression of established tumors [J]. Cancer Res, 2000, 60:4152-4160.
-
(2000)
Cancer Res
, vol.60
, pp. 4152-4160
-
-
Laird, A.D.1
Vajkoczy, P.2
Shawver, L.K.3
-
4
-
-
33744954585
-
Sunitinib in patients with metastatic renal cell carcinoma [J]
-
Motzer RJ, Rini BI, Bukowski RM, et al. Sunitinib in patients with metastatic renal cell carcinoma [J]. JAMA, 2006,295:2516-2524.
-
(2006)
JAMA
, vol.295
, pp. 2516-2524
-
-
Motzer, R.J.1
Rini, B.I.2
Bukowski, R.M.3
-
5
-
-
38849205563
-
-
Wen R, Zhou FS, Dong XC, et al. 1-Furfuryl-3-substituted-indolin-2-one derivatives, preparation and application: Chinese Patent, Applied No: 200610119183.4[P, 2006-12-05
-
Wen R, Zhou FS, Dong XC, et al. 1-Furfuryl-3-substituted-indolin-2-one derivatives, preparation and application: Chinese Patent, Applied No: 200610119183.4[P]. 2006-12-05.
-
-
-
-
6
-
-
0037468875
-
-
Sun L, Liang C, Shirazian S, et al. Discovery of 5-[5-fluoro-2-oxo-1, 2-dihydro indol-(3Z)-ylidenemethyl]-2, 4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethyl aminoethyl) amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase [J]. J Med Chem, 2003, 46:1116-1119.
-
Sun L, Liang C, Shirazian S, et al. Discovery of 5-[5-fluoro-2-oxo-1, 2-dihydro indol-(3Z)-ylidenemethyl]-2, 4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethyl aminoethyl) amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase [J]. J Med Chem, 2003, 46:1116-1119.
-
-
-
-
7
-
-
15144348824
-
Synthesis of oxindole [J]
-
Carlo FJ. Synthesis of oxindole [J]. J Am Chem Soc, 1944,66:1420-1420.
-
(1944)
J Am Chem Soc
, vol.66
, pp. 1420-1420
-
-
Carlo, F.J.1
-
8
-
-
0012519130
-
Fluorinated isatins and some of their heterocyclic derivatives [J]
-
Yen VQ, Buu-Hot NP, Xuong ND, Fluorinated isatins and some of their heterocyclic derivatives [J]. J Org Chem, 1958,23:1858-1861.
-
(1958)
J Org Chem
, vol.23
, pp. 1858-1861
-
-
Yen, V.Q.1
Buu-Hot, N.P.2
Xuong, N.D.3
-
9
-
-
0032474915
-
Synthesis and biological evaluations of 3-substituted indolin-2-ones: A novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases [J]
-
Sun L, Tran N, Tang F, et al. Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases [J]. J Med Chem, 1998,41:2588-2603.
-
(1998)
J Med Chem
, vol.41
, pp. 2588-2603
-
-
Sun, L.1
Tran, N.2
Tang, F.3
-
10
-
-
38849141048
-
New synthesis of the natural product 5,5′- oxydimethylene-bis-(2-furfural) [J]
-
Yu F, Wen R. New synthesis of the natural product 5,5′- oxydimethylene-bis-(2-furfural) [J]. Chin J Med Chem, 2002,12:285-286.
-
(2002)
Chin J Med Chem
, vol.12
, pp. 285-286
-
-
Yu, F.1
Wen, R.2
|